PARSIPPANY, NJ--(Marketwire - January 05, 2010) - The Medicines Company (NASDAQ: MDCO) will present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12th, in San Francisco, beginning at 2:30pm Pacific Standard Time, 5:30pm Eastern Standard Time. Clive A. Meanwell, Chairman and Chief Executive Officer, will provide a company overview and outlook in the presentation.
The session will be webcast with a link available at The Medicines Company’s website http://www.themedicinescompany.com under “Events.”
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company’s website is www.themedicinescompany.com.
Contact:
Robyn Brown
Vice President, Investor Relations
The Medicines Company
973-290-6000
investor.relations@themedco.com
